Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01723722 · ClinicalTrials.gov registry record · Phase 4
Treatment of Neonatal Abstinence Syndrome
A Phase 4 study of Neonatal Abstinence Syndrome, sponsored by Eastern Maine Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01723722: Completed Phase 4 study of Neonatal Abstinence Syndrome, sponsored by Eastern Maine Medical Center.
NCT01723722 is a Phase 4 study of Neonatal Abstinence Syndrome that has completed, run by Eastern Maine Medical Center. The registered enrollment target is 40 participants, below the 64-participant average among 17 other Neonatal Abstinence Syndrome trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01723722, a Phase 4 study of Neonatal Abstinence Syndrome, has completed, sponsored by Eastern Maine Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study compares treatment of Neonatal Abstinence Syndrome (NAS) with two different drugs for the difference in the length of treatment. This is a randomized, open-label comparison of phenobarbital and methadone versus phenobarbital and diluted deodorized tincture of opium (dDTO) where phenobarbital is the initial drug used to stabilize neonatal withdrawal.
Primary Outcome
Up to 12 months
Conditions Studied
Interventions
- DRUG Methadone
- DRUG Diluted Deodorized Tincture of Opium
Study Locations (1)
Maine
- Eastern Maine Medical Center - Bangor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-09 |
| Phase | Phase 4 |
What the finished NCT01723722 record still lists
NCT01723722 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 64-participant average among 17 other Neonatal Abstinence Syndrome trials with a reported enrollment target (37% lower).
The record links to 1 condition, with Neonatal Abstinence Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Methadone is the first listed.
NCT01723722 reports a single indexed study location in Maine.
Frequently Asked Questions
What is clinical trial NCT01723722 about?
NCT01723722 is a clinical study titled "Treatment of Neonatal Abstinence Syndrome". This study compares treatment of Neonatal Abstinence Syndrome (NAS) with two different drugs for the difference in the length of treatment. This is a randomized, open-label comparison of phenobarbital and methadone versus phenobarbital and diluted deodorized tincture of opium (dDTO) where phenobarbi...
What is the current status of trial NCT01723722?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2007-01. Estimated completion is 2009-09.
What conditions does trial NCT01723722 study?
This clinical trial studies the following conditions: Neonatal Abstinence Syndrome.
What interventions are being tested in trial NCT01723722?
The interventions under investigation include: Methadone (DRUG), Diluted Deodorized Tincture of Opium (DRUG).
Who is sponsoring clinical trial NCT01723722?
This trial is sponsored by Eastern Maine Medical Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01723722 being conducted?
This trial has 1 study location across Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neonatal Abstinence Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01723722's enrollment target sits among peer trials
40 14th of 17 higher than 4 of 17 other Neonatal Abstinence Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neonatal Abstinence Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy
ACTIVE NOT RECRUITING · Phase 4
-
Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome
COMPLETED · Phase 4
-
An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)
RECRUITING · NA
-
MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome
RECRUITING
-
A Trial to Determine Weight Gain Benefits of Caloric Supplementation for NAS Infants
ACTIVE NOT RECRUITING · NA
-
Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia